Technology
Here’s Why Pfizer and BioNTech Are Selling Their Vaccine at Cost – Motley Fool
The humanitarian move might help the companies gain additional for-profit contracts in the future.
Pfizer(NYSE:PFE) and BioNTech(NASDAQ:BNTX) recently agreed to sell their COVID-19 vaccine to the U.S. government at cost. In this video from Motley Fool Live, recorded on June 14, Fool.com contributors Brian Orelli and Keith Speights discuss why the companies…
Continue Reading
-
General22 hours agoMatildas vs Panama international friendly — live blog and scores from Bunbury
-
Noosa News23 hours agoPolice appeal for information after two men found dead
-
General23 hours agoTariff letters to 12 countries going out Monday: Trump
-
General23 hours agoCan the world be governed without the US? • Inside Story